Business Moderna says FDA refuses to review application for flu shot Finance News Feb 11, 2026 The Food and Drug Administration has refused to start a review of Moderna's application for its experimental flu… Read More...
Markets Canada in talks with Meta on return of news to Facebook as CUSMA review Finance News Jan 28, 2026 Listen to this articleEstimated 3 minutesThe audio version of this article is generated by AI-based technology.… Read More...
industry Meta suspends teen access to AI characters amid ongoing safety review Finance News Jan 24, 2026 I/O Fund lead tech analyst Beth Kindig explains why Google and OpenAI are both winners in AI on 'Making Money'.!-->-->… Read More...
Investing Nickel Price 2025 Year-End Review Finance News Dec 22, 2025 After peaking above US$20,000 per metric ton (MT) in May 2024, nickel prices have trended steadily down. Behind the… Read More...
Investing Crypto Market 2025 Year-End Review Finance News Dec 5, 2025 Q4 started strong for crypto and DeFi after a broadly bullish Q3, but the markets quickly slid into fear and… Read More...
Business Abortion pill mifepristone access steady under Trump, FDA review looms Finance News Nov 30, 2025 Mifepristone and Misoprostol pills are pictured Wednesday, Oct. 3, 2018, in Skokie, Illinois.Erin Hooley | Chicago… Read More...
Investing Agriculture Market Update: Q3 2025 in Review Finance News Nov 9, 2025 Fertilizer prices remained elevated in Q3 compared to both the first half of the year and the end of 2024. Potash… Read More...
Investing Zinc Price Update: H1 2025 in Review Finance News Aug 2, 2025 Zinc prices were in decline for much of the first half of 2025 as primary supply increased and demand from the… Read More...
Investing Uranium Price Update: Q2 2025 in Review Finance News Jul 29, 2025 The uranium market entered Q2 on shaky footing, with spot prices slipping to around US$63.50 per pound (March 13)—the… Read More...
Finance Biotech and Pharma Market Update: Q2 2025 in Review Finance News Jul 26, 2025 The second quarter of 2025 was a period of dynamic evolution within the biotech and pharma sectors. Critical factors… Read More...